Researchers track islet graft health after pancreas removal
NCT ID NCT03097185
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at blood markers and how well transplanted insulin-making cells (islets) work in people with chronic pancreatitis who have their pancreas removed and get their own islets back. Researchers will follow 100 adults for at least two years to understand graft function. The goal is to learn more, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor University Medical Center - Sammons Outpatient Cancer Center
RECRUITINGDallas, Texas, 75246, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will develop pancreatic cancer from chronic pancreatitis?
- Brain scans reveal hidden pain pathways in chronic pancreatitis
- New device aims to make pancreatic and bile duct procedures safer
- Scientists launch study to decode why diabetes affects people differently
- New study aims to reduce dangerous clots after complex pancreatic surgery
- Can immune clues predict pancreatic cancer in pancreatitis patients?